sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Avadel Pharmaceuticals
The Vanguard Group, Inc. has filed Form 8.3 with the Irish Takeover Panel, disclosing its position in Avadel Pharmaceuticals plc. As of November 6, 2025, Vanguard holds 5,523,410 ordinary shares, representing a 5.67% stake in Avadel.
This disclosure highlights Vanguard’s interest in relevant securities of Avadel, a requirement under the Irish Takeover Panel's rules for entities holding a position of 1% or more. The filing also notes recent transactions: the purchase of 462 shares and the sale of 396 shares, both at $18.71 per share.
No cash-settled derivative positions or agreements related to these securities were indicated. Furthermore, Vanguard reported no indemnity or dealing arrangements associated with Avadel securities.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.